Literature DB >> 7497720

Immunodepression following neurosurgical procedures.

K Asadullah1, C Woiciechowsky, W D Döcke, C Liebenthal, H Wauer, W Kox, H D Volk, S Vogel, R Von Baehr.   

Abstract

OBJECTIVE: To determine the influence of a selective, sterile central nervous system surgery on immune reactivity, particularly whether a decrease of monocytic human leukocyte antigen-DR expression, indicating immunodepression, occurs after neurosurgery and if this measurement is useful for identification of patients with a high risk of infection.
DESIGN: Prospective study.
SETTING: Department of neurosurgery and intensive care unit in a university hospital. PATIENTS AND
INTERVENTIONS: Blood samples were obtained from 46 patients at least once during the first 3 days after undergoing sterile central nervous system surgery. Fourteen of these patients developed infectious complications as defined by clinical and microbiological criteria. In ten of 46 patients, paired samples of blood and cerebrospinal fluid were collected from a ventricle drain at the following times: 1 day before surgery; several times on the day of surgery; and every day after surgery for at least 6 days.
MEASUREMENTS AND MAIN RESULTS: Monocytic human leukocyte antigen-DR expression, as measured by flow cytometry on days 1 through 3 after surgery in 46 patients, was lower in 14 patients who developed infection after neurosurgery (p < .0001). In all ten closely monitored patients, monocytic human leukocyte antigen-DR expression decreased temporarily after surgery. Of these patients, only one patient showed a persistent and considerably decreased monocytic human leukocyte antigen-DR expression. This patient was the only patient in this subgroup who developed sepsis syndrome. In order to assess whether the monocytic human leukocyte antigen-DR decrease was associated with a preceding inflammatory response, local and systemic concentrations of interleukin (IL)-1 beta, IL-6, IL-8, tumor necrosis factor-alpha, and interferon-gamma were measured in this subgroup. These cytokines were not detectable in plasma during the first days after surgery. In contrast, considerable increases of IL-6 and IL-8 concentrations were detectable in cerebrospinal fluid within hours after surgery.
CONCLUSIONS: A decrease of monocytic human leukocyte antigen-DR expression occurs after neurosurgery and is associated with a preceding, strong, intracranial (but not systemic) inflammatory response. A very low monocytic human leukocyte antigen-DR expression (< 30% positive monocytes) suggests the possibility of infection. Measurement of monocytic human leukocyte antigen-DR expression could help to detect patients with a high risk of infection after neurosurgery. Our results suggest that even sterile central nervous system surgery may contribute to general immunodepression. The local intracranial inflammatory response may be involved in this process.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7497720     DOI: 10.1097/00003246-199512000-00006

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  17 in total

1.  Acquired immunoparalysis in paediatric intensive care: prospective observational study.

Authors:  M Peters; A Petros; G Dixon; D Inwald; N Klein
Journal:  BMJ       Date:  1999-09-04

2.  Relevance of cerebral interleukin-6 after aneurysmal subarachnoid hemorrhage.

Authors:  Asita Sarrafzadeh; Florian Schlenk; Christine Gericke; Peter Vajkoczy
Journal:  Neurocrit Care       Date:  2010-12       Impact factor: 3.210

Review 3.  Monocyte deactivation--rationale for a new therapeutic strategy in sepsis.

Authors:  H D Volk; P Reinke; D Krausch; H Zuckermann; K Asadullah; J M Müller; W D Döcke; W J Kox
Journal:  Intensive Care Med       Date:  1996-10       Impact factor: 17.440

4.  Effect of time, injury, age and ethanol on interpatient variability in valproic acid pharmacokinetics after traumatic brain injury.

Authors:  Gail D Anderson; Nancy R Temkin; Asaad B Awan; H Richard Winn; Richard H Winn
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

5.  Postoperative immunosuppression markers and the occurrence of sepsis in patients with benign and malignant disease.

Authors:  Tamara Alkhamis; Dubravka Ivić; Jasenka Wagner; Josip Ivić; Blaženka Dobrošević; Ivana Turina; Kristina Kralik; Jerko Barbić
Journal:  Wien Klin Wochenschr       Date:  2014-10-03       Impact factor: 1.704

6.  Effect of Traumatic Brain Injury, Erythropoietin, and Anakinra on Hepatic Metabolizing Enzymes and Transporters in an Experimental Rat Model.

Authors:  Gail D Anderson; Todd C Peterson; Cole Vonder Haar; Fred M Farin; Theo K Bammler; James W MacDonald; Eric D Kantor; Michael R Hoane
Journal:  AAPS J       Date:  2015-06-12       Impact factor: 4.009

Review 7.  Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation?

Authors:  W L Biffl; E E Moore; F A Moore; V M Peterson
Journal:  Ann Surg       Date:  1996-11       Impact factor: 12.969

8.  Influence of surgical intervention in the immune response of severely injured patients.

Authors:  Sascha Flohé; Sven Lendemans; Fritz-Ulrich Schade; Ernst Kreuzfelder; Christian Waydhas
Journal:  Intensive Care Med       Date:  2003-11-07       Impact factor: 17.440

Review 9.  Immune response of severely injured patients--influence of surgical intervention and therapeutic impact.

Authors:  S Flohé; S B Flohé; F U Schade; C Waydhas
Journal:  Langenbecks Arch Surg       Date:  2007-06-29       Impact factor: 3.445

10.  HLA-DR as a marker for increased risk for systemic inflammation and septic complications after cardiac surgery.

Authors:  Wolfgang Oczenski; Herbert Krenn; Ruth Jilch; Herbert Watzka; Ferdinand Waldenberger; Ursula Köller; Sylvia Schwarz; Robert D Fitzgerald
Journal:  Intensive Care Med       Date:  2003-06-12       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.